Wenger Vieli advised the shareholders of moneyland on the sale. Moneyland, Switzerland’s leading independent financial comparison platform, on all Swiss legal matters in connection with its...
SMG Swiss Marketplace Group AG’s Acquisition Of Moneyland
NLS Pharmaceutics’ Common Shares Private Placement
Wenger Vieli acted as Swiss legal advisor to NLS Pharmaceutics on the issuance. NLS Pharmaceutics has completed the registered direct offering and concurrent private placement transaction with...
Indie Semiconductor’s Acquisition of EXALOS
Wenger Vieli advised sell-side in the sale transaction of EXALOS to indie Semiconductor advised by Kellerhals Carrard. EXALOS, a Swiss company specializing in high-performance optical semiconductors,...
Carvolution’s CHF 16.2 Million Series D Financing Round
Wenger Vieli advised the lead investor Redalpine Opportunity Fund on the deal. Car subscription pioneer Carvolution has successfully closed a new financing round to further strengthen...
LatticeFlow AG’s $12 Million Series A Financing Round
Homburger advised lead investors Atlantic Bridge Capital and OpenOcean on the deal. Wenger Vieli advised LatticeFlow. LatticeFLow AG, an ETH spin-off pioneering in robust artificial intelligence...
NLS Pharmaceutics’ $4 Million Private Placement and Conversion of Existing Short-Term Notes
Wenger Vieli advised NLS Pharmaceutics on the deal. NLS Pharmaceutics Ltd., a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for...
PAR Technology’s Acquisition of MENU Technologies
Wenger Vieli advised the shareholders of MENU Technologies Ltd on the deal. MENU has become part of the NYSE listed PAR Technology Corp. group. The MENU...
NLS Pharmaceutics’ US$4.4 Million Registered Direct Offering
Wenger Vieli advised NLS Pharmaceutics on the deal. NLS Pharmaceutics Ltd, a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients...
NLS Pharmaceutics’ US$4.4 Million Registered Direct Offering
Wenger Vieli advised NLS Pharmaceutics on the deal. NLS Pharmaceutics Ltd, a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients...
Unigestion’s Acquisition of Home Instead
Homburger advised Credit Suisse (Switzerland) Ltd. in connection with the financing of the acquisition. Bär & Karrer acted as legal advisor to the sellers in this...
Klingel Medical Metal’s Acquisition of Ruetschi Group
Renzenbrink & Partner, Wenger Vieli and Milbank advised Klingel medical metal on the deal. Bär & Karrer acted as legal advisor to the sellers in this...
Atlas Antibodies’ Acquisition of Evitria Group
VISCHER advised the sellers on this transaction. Wenger Vieli advised Atlas Antibodies. The shareholders of the evitria Group have sold the evitria Group to Atlas Antibodies,...